RxDoctor Payments Data

Ismail Omran

Nephrology · Sioux Falls, SDNPI 1023539590

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $521, more than ten times the $41 reported in 2021. Among nephrology clinicians in SD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,049in general payments, 2019–2025

Across 25 payments — averaging $41.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Calliditas Therapeutics US Inc.$179
  • Scpharmaceuticals Inc.$159
  • Sanofi$149
  • Travere Therapeutics, Inc.$138
  • Akebia Therapeutics Inc$107
  • BTG International Inc.$79
  • plus $237 from 7 others

What the payments were for

  • Food & beverage$1,03298%
  • Education$172%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,049 in reported general payments places this provider in the 90th percentile of 26 nephrology providers in South Dakota.

See all nephrology providers in South Dakota

Medicare billing

Part B allowed, 2024
$235,521
Medicare patients
576
Services billed
2,313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol28$28,910
JardianceEmpagliflozin19$21,299
Calcitriol444$5,879
LokelmaSodium Zirconium Cyclosilicate14$5,784
Calcium Acetate38$2,519
Tamsulosin Hcl72$1,777
Losartan Potassium148$1,452
Diltiazem 24hr Er (La)Diltiazem Hcl13$1,332
Potassium Chloride52$1,007
Sevelamer Carbonate12$1,005
Hydralazine Hcl39$901
Allopurinol75$733
Bumetanide19$561
Diltiazem 24hr Er (Cd)Diltiazem Hcl22$539
Furosemide120$512

Paid to pharmacies, not to this prescriber.

Other nephrology in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →